跳至主要内容
临床试验/NCT04070365
NCT04070365已完成不适用

FLEX Arteriovenous Access Registry

VentureMed Group Inc.10 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2018年5月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
114
试验地点
10
主要终点
Anatomic Success

研究概览

简要总结

Evaluation of the FLEX Vessel Prep system combined with angioplasty in the treatment of arteriovenous access stenosis.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hemodialysis patient currently scheduled to undergo an intervention of their arteriovenous fistula or graft due to clinical or hemodynamic abnormalities.
  • The patient is ≥18 years of age. Patient is legally competent, has been informed of the study, voluntarily agrees to participate, and has signed the inform consent form.
  • The patient has a reasonable expectation of remaining on hemodialysis for 12 months.
  • The patient understands the study and is willing and able to comply with follow-up requirements.
  • The patient is willing to provide informed consent.

排除标准

  • The patient has a known or suspected systemic infection.
  • The patient has a known or suspected infection of the hemodialysis graft.
  • The patient has an untreatable allergy to radiographic contrast material.
  • In the opinion of the operating physician, the patient's hemodialysis access is unsuitable for endovascular treatment.

结局指标

主要结局

Anatomic Success

时间窗: At the completion of the index procedure

Defined as the angiographic percentage of stenosis post procedure as \<30%

次要结局

  • Procedural Success(6 Months)
  • Access Secondary Patency(6, 9, and 12 Months)
  • Technical Success of the Device(At the index procedure)
  • Clinical Success(6 Months)
  • Circuit Primary Patency(6, 9, and Months)
  • Target Lesion Primary Patency(6, 9 and 12 Months)
  • Assisted Primary Patency(6, 9, and 12 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验